# Clinical Study of 68Ga-LNC1007 Injection PET/CT

> **NCT06463782** · PHASE1 · COMPLETED · sponsor: **Yantai LNC Biotechnology Singapore PTE. LTD.** · enrollment: 8 (actual)

## Conditions studied

- Healthy Volunteers
- Cancer Patients

## Interventions

- **DRUG:** 68Ga-LNC1007 Injection

## Key facts

- **NCT ID:** NCT06463782
- **Lead sponsor:** Yantai LNC Biotechnology Singapore PTE. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-02
- **Primary completion:** 2025-05-27
- **Final completion:** 2025-05-27
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06463782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06463782, "Clinical Study of 68Ga-LNC1007 Injection PET/CT". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06463782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*